Cargando…

Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease

Levodopa and, later, deep brain stimulation (DBS) have become the mainstays of therapy for motor symptoms associated with Parkinson's disease (PD). Although these therapeutic options lead to similar clinical outcomes, the neural mechanisms underlying their efficacy are different. Therefore, inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mueller, Karsten, Jech, Robert, Růžička, Filip, Holiga, Štefan, Ballarini, Tommaso, Bezdicek, Ondrej, Möller, Harald E., Vymazal, Josef, Růžička, Evžen, Schroeter, Matthias L., Urgošík, Dušan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051673/ https://www.ncbi.nlm.nih.gov/pubmed/30035027 http://dx.doi.org/10.1016/j.nicl.2018.05.006

Ejemplares similares

Differential effects of deep brain stimulation and levodopa on brain activity in Parkinson’s disease
por: Mueller, Karsten, et al.
Publicado: (2020)

Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
por: Mueller, Karsten, et al.
Publicado: (2018)

The Instrumental Activities of Daily Living in Parkinson’s Disease Patients Treated by Subthalamic Deep Brain Stimulation
por: Bezdicek, Ondrej, et al.
Publicado: (2022)

Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem
por: Holiga, Štefan, et al.
Publicado: (2015)

The Subthalamic Microlesion Story in Parkinson's Disease: Electrode Insertion-Related Motor Improvement with Relative Cortico-Subcortical Hypoactivation in fMRI
por: Jech, Robert, et al.
Publicado: (2012)

Weight Gain Is Associated with Medial Contact Site of Subthalamic Stimulation in Parkinson's Disease
por: Růžička, Filip, et al.
Publicado: (2012)

Regional gray matter changes and age predict individual treatment response in Parkinson's disease
por: Ballarini, Tommaso, et al.
Publicado: (2018)

Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
por: Ballarini, Tommaso, et al.
Publicado: (2018)

General and selective brain connectivity alterations in essential tremor: A resting state fMRI study
por: Mueller, Karsten, et al.
Publicado: (2017)

Motor Matters: Tackling Heterogeneity of Parkinson’s Disease in Functional MRI Studies
por: Holiga, Štefan, et al.
Publicado: (2013)

Frequency-phase analysis of resting-state functional MRI
por: Goelman, Gadi, et al.
Publicado: (2017)

Corrigendum: Frequency-phase analysis of resting-state functional MRI
por: Goelman, Gadi, et al.
Publicado: (2017)

Separate neural representations of depression, anxiety and apathy in Parkinson’s disease
por: Dan, Rotem, et al.
Publicado: (2017)

Topography of emotional valence and arousal within the motor part of the subthalamic nucleus in Parkinson’s disease
por: Serranová, Tereza, et al.
Publicado: (2019)

Accounting for Movement Increases Sensitivity in Detecting Brain Activity in Parkinson's Disease
por: Holiga, Štefan, et al.
Publicado: (2012)

Abnormal Activity in the Precuneus during Time Perception in Parkinson's Disease: An fMRI Study
por: Dušek, Petr, et al.
Publicado: (2012)

Basal Ganglia Neuronal Activity during Scanning Eye Movements in Parkinson’s Disease
por: Sieger, Tomáš, et al.
Publicado: (2013)

Benefits of pallidal stimulation in dystonia are linked to cerebellar volume and cortical inhibition
por: Fečíková, Anna, et al.
Publicado: (2018)

Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI Study
por: Mueller, Karsten, et al.
Publicado: (2017)

Symptom-severity-related brain connectivity alterations in functional movement disorders
por: Mueller, Karsten, et al.
Publicado: (2022)

Predicting Falls in Parkinson Disease: What Is the Value of Instrumented Testing in OFF Medication State?
por: Hoskovcová, Martina, et al.
Publicado: (2015)

The Role of Levodopa Challenge in Predicting the Outcome of Subthalamic Deep Brain Stimulation
por: Wolke, Robin, et al.
Publicado: (2023)

Does serial administration of gadolinium‐based contrast agents affect patient neurological and neuropsychological status? Fourteen‐year follow‐up of patients receiving more than fifty contrast administrations
por: Vymazal, Josef, et al.
Publicado: (2019)

Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease
por: Kim, Ji Hee, et al.
Publicado: (2015)

Pallidal versus subthalamic nucleus deep brain stimulation for levodopa‐induced dyskinesia
por: Fan, Shi‐Ying, et al.
Publicado: (2019)

Pseudobulbar laughter as a levodopa off phenomenon exacerbated by subthalamic deep brain stimulation
por: Chattha, P. K., et al.
Publicado: (2015)

Subthalamic deep brain stimulation induces finely-tuned gamma oscillations in the absence of levodopa
por: Wiest, C., et al.
Publicado: (2021)

Brain Damage With Heart Failure: Cardiac Biomarker Alterations and Gray Matter Decline
por: Mueller, Karsten, et al.
Publicado: (2020)

Disentangling brain functional network remodeling in corticobasal syndrome – A multimodal MRI study
por: Ballarini, Tommaso, et al.
Publicado: (2019)

Evaluation of the Direct Effect of Bilateral Deep Brain Stimulation of the Subthalamic Nucleus on Levodopa-Induced On-Dyskinesia in Parkinson's Disease
por: Li, Jiping, et al.
Publicado: (2021)

3D visual cueing shortens the double support phase of the gait cycle in patients with advanced Parkinson's disease treated with DBS of the STN
por: Poláková, Kamila, et al.
Publicado: (2020)

Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson’s Disease for Deep Brain Stimulation of the Subthalamic Nucleus
por: Aygun, Dursun, et al.
Publicado: (2016)

Effects of Subthalamic Nucleus Deep Brain Stimulation and Levodopa on Balance in People with Parkinson’s Disease: A Cross Sectional Study
por: May, David S., et al.
Publicado: (2020)

Balance response to levodopa predicts balance improvement after bilateral subthalamic nucleus deep brain stimulation in Parkinson’s disease
por: Yin, Zixiao, et al.
Publicado: (2021)

Controlled-Release Levodopa for the Treatment of Rapid Motor Fluctuations in Parkinson's Disease Subjects with Subthalamic Nucleus Deep Brain Stimulation
por: Onder, Halil, et al.
Publicado: (2023)

Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
por: Picillo, Marina, et al.
Publicado: (2020)

Directed functional connectivity of the sensorimotor system in young and older individuals
por: Goelman, Gadi, et al.
Publicado: (2023)

Magnetic susceptibility changes in the brainstem reflect REM sleep without atonia severity in isolated REM sleep behavior disorder
por: Nepozitek, Jiri, et al.
Publicado: (2023)

Benefits of Levodopa-Carbidopa Intestinal Gel Infusion in Patients with Parkinson’s Disease Experiencing Gait Dysfunction Following Subthalamic Deep Brain Stimulation
por: Kimber, Thomas Edmund, et al.
Publicado: (2019)

Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson’s disease
por: Li, Kai, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2fqqsq5hk3r60hnn3fdhv75slq